TITLE

Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor

AUTHOR(S)
Toshiharu Iwasaki; Wataru Miyazaki; Akira Takeshita; Yukio Koibuchi; Jun Horiguchi; Noriaki Shimokawa; Yuichi Iino; Yasuo Morishita; Noriyuki Koibuchi
PUB. DATE
June 2008
SOURCE
Endocrine (1355008X);Jun2008, Vol. 33 Issue 3, p305
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  The estrogen receptor (ER) is a key regulator of proliferation and differentiation in breast cancer cells. In the present study, the effect of steroid and xenobiotic receptor (SXR) on 17β-estradiol (E2)-induced transcription through ERα was studied. SXR augmented ER-mediated transcription in the presence of E2 in MCF-7 breast cancer-derived cells and CV-1 fibroblast-derived cells. On the other hand, SXR alone did not affect the estrogen response element (ERE)-containing promoter activity in CV-1 cells. SXR did not directly bind to ERα or ERE in vitro, indicating that SXR may affect ER-mediated transcription by altering cofactor binding to ER. Although SXR did not alter the binding between ERα and p300/CBP interacting protein (p/CIP), it decreased the binding of a specific corepressor, silencing mediator of retinoid and thyroid hormone receptors (SMRT) to liganded ERα as assessed by mammalian two-hybrid, glutathione S-transferase pull-down, immunoprecipitation and newly developed Liquid Chemiluminescent DNA Pull-Down Assays. These results indicate that SXR augmented ER-mediated transcription by dissociating SMRT from ERα. Thus, the expression of SXR in breast cancer cells may alter the ER signaling, which may play crucial role for growth and differentiation of breast cancer cells.
ACCESSION #
44228784

 

Related Articles

  • Transcription Factor Ets1 Cooperates with Estrogen Receptor α to Stimulate Estradiol-Dependent Growth in Breast Cancer Cells and Tumors. Kalet, Brian T.; Anglin, Sara R.; Handschy, Anne; O’Donoghue, Liza E.; Halsey, Charles; Chubb, Laura; Korch, Christopher; Duval, Dawn L. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The purpose of this study was to explore the role of transcription factor Ets1 in estrogen receptor α (ERα)-positive breast cancer progression. We expressed human Ets1 or empty vector in four human ERα-positive breast cancer cell lines and observed increased colony formation. Further...

  • Effects of Celecoxib and Ly117018 Combination on Human Breast Cancer Cells in Vitro. Baumann, Klaus H.; Klusmeier, Elmar; Eggemann, Isabel; Reinartz, Silke; Almeroth, Achim; Mathias6Kalder; Wagner, Uwe // Breast Cancer: Basic & Clinical Research;2009, Issue 3, p23 

    Activation and signalling of estrogen receptor (ER) and COX-2 represent two important pathways in breast cancer cell regulation. Activation of either pathway is associated with breast cancer cell proliferation and eventually malignant progression. Raloxifene analogue, Ly117018, a selective...

  • Coexposure to Phytoestrogens and Bisphenol A Mimics Estrogenic Effects in an Additive Manner. Katchy, Anne; Pinto, Caroline; Jonsson, Philip; Nguyen-Vu, Trang; Pandelova, Marchela; Riu, Anne; Schramm, Karl-Werner; Samarov, Daniel; Gustafsson, Jan-Åke; Bondesson, Maria; Williams, Cecilia // Toxicological Sciences;Mar2014, Vol. 138 Issue 1, p21 

    Endocrine-disrupting chemicals (EDC) are abundant in our environment. A number of EDCs, including bisphenol A (BPA) can bind to the estrogen receptors (ER), ERα and ERβ, and may contribute to estrogen-linked diseases such as breast cancer. Early exposure is of particular concern; many EDCs...

  • Functional regulation of oestrogen receptor pathway by the dynein light chain 1. Rayala, Suresh K.; de Hollander, Petra; Balasenthil, Seetharaman; Zhibo Yang; Broaddus, Russell R.; Kumar, Rakesh // EMBO Reports;Jun2005, Vol. 6 Issue 6, p538 

    Overexpression and phosphorylation of dynein light chain 1 (DLC1) have been shown to promote the growth of breast cancer cells. However, the role of DLC1 in the action of the oestrogen receptor (ER) remains unknown. Here, we found that oestrogen induces the transcription and expression of DLC1....

  • Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells. Sunzoo Kim; Tae In Park // International Journal of Clinical & Experimental Medicine;2013, Vol. 6 Issue 10, p890 

    Naringenin is present abundantly in citrus fruits and is one of the natural alternatives to synthetic estrogen, but the mechanism of how naringenin functions is not well known. Our study revealed that the relative estrogenic potency of the substances was E2 > genistein > naringenin. Naringenin...

  • Downregulation of Steroid Receptor Coactivator-2 Modulates Estrogen-Responsive Genes and Stimulates Proliferation of MCF-7 Breast Cancer Cells. Fenne, Ingvild S.; Helland, Thomas; Flågeng, Marianne H.; Dankel, Simon N.; Mellgren, Gunnar; Sagen, Jørn V. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The p160/Steroid Receptor Coactivators SRC-1, SRC-2/GRIP1, and SRC-3/AIB1 are important regulators of Estrogen Receptor alpha (ERα) activity. However, whereas the functions of SRC-1 and SRC-3 in breast tumourigenesis have been extensively studied, little is known about the role of SRC-2....

  • The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17β-estradiol on breast cancer cell lines. Ström, Anders; Arai, Naoya; Leers, Jörg; Gustafsson, Jan-Åke // Oncogene;11/30/2000, Vol. 19 Issue 51, p5951 

    The mechanism behind hormone dependent growth of breast cancer is presently not well understood. We show that the HES-1 protein level in the breast cancer cell lines T47D and MCF-7 is down regulated by 17β-estradiol treatment. This regulation could be reversed by addition of the...

  • MicroRNAs: Are they indicators for prediction of response to radiotherapy in breast cancer? Halimi, Mohammad; Parsian, Hadi; Mohsen Asghari, S.; Sariri, Reyhaneh; Moslemi, Dariush; Yeganeh, Farshid // Journal of Medical Hypotheses & Ideas;Jul2013, Vol. 7 Issue 2, p59 

    Abstract: Radiotherapy is one of the most important methods for the treatment of breast cancer. There is great interest in identifying factors that help to predict patient response to radiotherapy. MicroRNAs (miRNAs) are a class of small RNA molecules that regulate gene expression at the...

  • Integrative Nuclear Signaling in Cell Development—A Role for FGF Receptor-1. Stachowiak, Michal K.; Maher, Pamela A.; Stachowiak, Ewa K. // DNA & Cell Biology;Dec2007, Vol. 26 Issue 12, p811 

    Ontogeny requires the coordinated regulation of multigene programs by a plethora of extracellular and intracellular signals, thereby allowing cells to transition between different states, including proliferation and differentiation. Disruption of this regulation can result in oncogenic...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics